The share
Cell Impact's share is listed on the Nasdaq First North Growth Market, a Nordic marketplace for small and medium-sized growth companies. The share is named Cell Impact B and the ticker symbol is CI, with the ISIN code SE0017885379.
According to Cell Impact’s Articles of Association, the share capital shall be no less than SEK 50,000,000 and no more than SEK 200,000,000, divided into no fewer than 250,000,000 shares and no more than 1,000,000,000 shares. As of December 31, 2025, the registered share capital in Cell Impact amounted to SEK 58,916,949 divided into 294,584,745 shares. All shares are of the same type and confer equal rights in the company as well as equal rights to the company’s assets and profits. The shares have a quota value of approximately SEK 0.20.
Share graph
Owner List
Development of share capital and number of shares in 2025
As per 30 september 2025.
| Year | Event | Change share capital (SEK) | Change shares | Share capital (SEK) | Number of shares | Quota value (SEK) |
|---|---|---|---|---|---|---|
| 2025 | Opening values 1/1 2025 | 80,597,667.04 | 696,279,128 | 0.12 | ||
| 2025 | Reduction of share capital | -66,672,244.48 | – | 13,925,422.56 | 696,279,128 | 0.02 |
| 2025 | Rights issue | 39,231,526.56 | 1,961,576,328 | 53,156,949.12 | 2,657,847,456 | 0.02 |
| 2025 | Bonus issue | 29,073,604.00 | – | 82,230,553.12 | 2,657,847,456 | 0.03 |
| 2025 | Reduction of share capital | -29,073,604.00 | – | 53,156,949.12 | 2,657,847,456 | 0.02 |
| 2025 | Directed issue | 5,760,000.00 | 288,000,000 | 58,916,949.12 | 2,945,847,456 | 0.02 |
| 2025 | Share consolidation 1:10 | – | -2,651,262,711 | 58,916,949.12 | 294,584,745 | 0.20 |
Historic development
Historic development of share capital as of October 1, 2024
| Change | Number of shares | |||||||
| Year | Event | A shares | B shares | A shares | B shares | Total | Quota value | Share capital |
| 1999 | New establishment | 0 | 3,800,000 | 0 | 3,800,000 | 3,800,000 | 1.00 | 3,800,000 |
| 2012 | Directed share issue | 0 | 1,200,000 | 0 | 5,000,000 | 5,000,000 | 0.10 | 500,000 |
| 2012 | Reverse split | 0 | -680,574 | 0 | 4,319,426 | 4,319,426 | 0.12 | 500,000 |
| 2012 | Conversion | 72,600 | -72,600 | 72,600 | 4,246,826 | 4,319,426 | 0.12 | 500,000 |
| 2013 | Rights issue | 72,600 | 4,246,826 | 145,200 | 8,493,652 | 8,638,852 | 0.12 | 1,000,000 |
| 2016 | Directed share issue | 0 | 526,000 | 145,200 | 9,019,652 | 9,164,852 | 0.12 | 1,060,888 |
| 2016 | Rights issue | 72,600 | 4,509,826 | 217,800 | 13,529,478 | 13,747,278 | 0.12 | 1,591,332 |
| 2018 | Rights issue | 0 | 3,901,218 | 217,800 | 17,430,696 | 17,648,496 | 0.12 | 2,098,485 |
| 2018 | Directed share issue | 0 | 480,000 | 217,800 | 17,910,696 | 18,128,496 | 0.12 | 2,098,485 |
| 2018 | Directed share issue | 0 | 7,999,968 | 217,800 | 25,910,664 | 26,128,464 | 0.08 | 2,098,485 |
| 2019 | Rights issue | 0 | 18,128,496 | 217,800 | 44,039,160 | 44,256,960 | 0.06 | 2,638,677 |
| 2019 | Directed share issue | 0 | 1,191,701 | 217,800 | 45,230,861 | 45,448,661 | 0.12 | 5,260,962 |
| 2020 | Exercise of warrants | 0 | 6,393,673 | 217,800 | 51,624,534 | 51,842,334 | 0.10 | 5,260,962 |
| 2020 | Directed share issue | 0 | 7,000,000 | 217,800 | 58,624,534 | 58,842,334 | 0.12 | 6,811,362 |
| 2021 | Rights issue | 0 | 16,812,094 | 217,800 | 75,436,628 | 75,654,428 | 0.12 | 8,757,466 |
| 2022 | Restamping | -217,800 | 217,800 | 0 | 75,654,428 | 75,654,428 | 0.12 | 8,757,466 |
| 2022 | Exercise of warrants | 0 | 172,500 | 0 | 75,826,928 | 75,826,928 | 0.12 | 8,777,433 |
| 2023 | Rights issue | 0 | 515,623,104 | 0 | 591,450,032 | 591,450,032 | 0.12 | 68,463,980 |
| 2024 | Exercise of warrants | 0 | 104,821,096 | 0 | 696,271,128 | 696,271,128 | 0,12 | 80,597,667 |